KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Castle Biosciences (CSTL) Other Gross PP&E Adjustments (2018 - 2026)

Castle Biosciences' Other Gross PP&E Adjustments history spans 8 years, with the latest figure at $94.5 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 99.99% to $94.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $94.5 million, a 99.99% increase, with the full-year FY2025 number at $94.5 million, up 99.99% from a year prior.
  • Other Gross PP&E Adjustments hit $94.5 million in Q4 2025 for Castle Biosciences, up from $86.6 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CSTL hit a ceiling of $94.5 million in Q4 2025 and a floor of $421000.0 in Q1 2022.
  • Historically, Other Gross PP&E Adjustments has averaged $29.9 million across 5 years, with a median of $17.1 million in 2022.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 95.64% in 2022 and later skyrocketed 2840.14% in 2023.
  • Tracing CSTL's Other Gross PP&E Adjustments over 5 years: stood at $3.0 million in 2021, then surged by 489.66% to $17.4 million in 2022, then decreased by 3.55% to $16.8 million in 2023, then surged by 180.84% to $47.2 million in 2024, then soared by 99.99% to $94.5 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for CSTL at $94.5 million in Q4 2025, $86.6 million in Q3 2025, and $74.1 million in Q2 2025.